MAPT and Alzheimer disease: Emerging evidence suggest that AD is more heterogeneous than previously thought (the classical pathologic hallmarks, amyloid and tau, were not the most frequent findings in the brain of the oldest old) has supported the opinion that AD may be a syndrome and not a disease.